Compare StocksHCA vs TSLA

HCA Healthcare, Inc. (HCA) vs Tesla, Inc. (TSLA): Which Is the Better Buy in 2026?

As of 2026-06-19, HCA is undervalued at $375, with a DCF intrinsic value of $523 and a margin of safety of 28%. TSLA is overvalued at $400, with an intrinsic value of $131 and a margin of safety of -206%. Of the two, HCA has the wider margin of safety.

HCA
HCA Healthcare, Inc.
$375.17
VS
TSLA
Tesla, Inc.
$400.49

Rewards

HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.
TSLA
  • Altman Z-Score of 19.94 indicates very low bankruptcy risk — the company is firmly in the safe zone.
  • Net debt/EBITDA of -2.6x means the company holds more cash than debt — a net cash position.

Risks

HCA
    TSLA
    • ROIC has declined by 21.5 percentage points over the past 4 years, which may signal competitive erosion.
    • Gross margin of 19.1% is low, suggesting a competitive or commodity-like market with limited pricing power.
    • Share count has increased by 19% over the past 4 years, diluting existing shareholders.

    Key Valuation Metrics

    Learn more →
    HCA
    TSLA
    Valuation
    $7.69B
    Free Cash Flow
    $5.25B
    9.24%
    FCF Yield
    0.35%
    12.93
    Trailing P/E
    367.42
    11.33
    Forward P/E
    160.20
    Quality & Moat
    18.14%
    ROIC
    3.23%
    N/A
    ROE
    4.90%
    41.61%
    Gross Margin
    19.06%
    1.20
    PEG Ratio
    5.78
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    Net cash
    N/A
    Interest Coverage
    N/A
    3.13
    Net Debt / EBITDA
    -2.60
    0.76%
    Dividend Yield
    0.00%
    HCA: 8Ties: 1TSLA: 1
    HCATSLA

    Historical Fundamentals

    Learn more →
    HCA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    TSLA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    HCA
    $2.43
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $15.76B
    Δ Market Cap
    +$38.30B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    TSLA
    $50.04
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $25.92B
    Δ Market Cap
    +$1.30T
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    HCA
    28.2% Margin of Safety
    Price is 28.2% below estimated fair value
    Current Price: $375.17
    Fair Value: $522.55
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    TSLA
    626.9% Overvalued
    Price is 626.9% above estimated fair value
    Current Price: $400.49
    Fair Value: $55.09
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    HCA

    What growth rate is the market pricing in at $375?

    +7.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +5.6%

    The market implies +7.3% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +5.6%, reflecting ongoing growth investment.

    TSLA

    What growth rate is the market pricing in at $400?

    +50.2%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +45.1%

    The market implies +50.2% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +45.1%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    HCA
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    TSLA
    31/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable moat detected, though revenue predictability shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    HCA
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    TSLA
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    HCA
    Insiders 16.2%Institutions 78.3%Retail & Other 5.5%
    No. of Institutional Holders1,952
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    TSLA
    Insiders 11.1%Institutions 44.9%Retail & Other 44.0%
    No. of Institutional Holders5,237
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    HCA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    TSLA
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $999.96M
    MUSK ELON REEVE
    Chief Executive Officer
    $999.96M
    @ $389.28 · 2025-09-12
    GEBBIA JOSEPH
    Director
    $1.03M
    @ $256.31 · 2025-04-24
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    HCA
    0
    Sells (3M)
    7
    Sells (12M)
    Total value (12M): $32.73M
    MCALEVEY MICHAEL R.
    Officer
    $903,537
    @ $533.37 · 2026-02-18
    WYATT CHRISTOPHER F
    Officer
    $2.02M
    @ $505.00 · 2026-02-11
    BERRES JENNIFER
    Officer
    $4.13M
    @ $514.58 · 2026-02-11
    HAZEN SAMUEL N
    Chief Executive Officer
    $21.48M
    @ $501.04 · 2026-02-03
    CUFFE MICHAEL S
    Officer
    $747,135
    @ $498.09 · 2026-02-03
    MCALEVEY MICHAEL R.
    Officer
    $1.84M
    @ $473.79 · 2025-11-05
    CUFFE MICHAEL S
    Officer
    $1.61M
    @ $418.84 · 2025-09-08
    FOSTER JON MARK
    Officer
    $5.80M
    @ $369.32 · 2025-05-13
    BERRES JENNIFER
    Officer
    $3.08M
    @ $322.59 · 2025-02-14
    BILLINGTON PHILLIP G
    Officer
    $1.36M
    @ $350.00 · 2024-11-14
    WHALEN KATHLEEN M
    Officer
    $527,677
    @ $357.99 · 2024-11-14
    AKDAMAR EROL R
    Officer
    $1.02M
    @ $353.00 · 2024-11-14
    CUFFE MICHAEL S
    Officer
    $3.22M
    @ $385.42 · 2024-09-12
    WHALEN KATHLEEN M
    Officer
    $1.76M
    @ $362.13 · 2024-07-31
    WYATT CHRISTOPHER F
    Officer
    $1.44M
    @ $360.20 · 2024-07-29
    REINER DEBORAH M
    Officer
    $1.19M
    @ $359.96 · 2024-07-29
    TORRES KATHRYN A
    Officer
    $659,328
    @ $355.05 · 2024-07-25
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    TSLA
    4
    Sells (3M)
    10
    Sells (12M)
    Total value (12M): $62.72M
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.05M
    @ $402.27 · 2026-06-08
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.35M
    @ $450.00 · 2026-05-13
    WILSON - THOMPSON KATHLEEN
    Director
    $9.99M
    @ $378.11 · 2026-04-30
    WILSON - THOMPSON KATHLEEN
    Director
    $9.27M
    @ $359.33 · 2026-03-30
    TANEJA VAIBHAV
    Chief Financial Officer
    $899,077
    @ $397.12 · 2026-03-06
    WILSON - THOMPSON KATHLEEN
    Director
    $10.69M
    @ $415.56 · 2026-02-25
    MUSK KIMBAL J
    Director
    $25.61M
    @ $450.66 · 2025-12-09
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.17M
    @ $443.93 · 2025-12-08
    TANEJA VAIBHAV
    Chief Financial Officer
    $918,137
    @ $352.45 · 2025-09-08
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.77M
    @ $295.26 · 2025-07-08
    ZHU XIAOTONG
    Officer
    $4.86M
    @ $323.81 · 2025-06-12
    TANEJA VAIBHAV
    Chief Financial Officer
    $732,573
    @ $285.71 · 2025-06-09
    TANEJA VAIBHAV
    Chief Financial Officer
    $2.40M
    @ $342.30 · 2025-06-03
    EHRENPREIS IRA MATTHEW
    Director
    $170.64M
    @ $357.30 · 2025-05-27
    MUSK KIMBAL J
    Director
    $32.73M
    @ $357.39 · 2025-05-27
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.05M
    @ $350.11 · 2025-05-16
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.20M
    @ $300.00 · 2025-05-09
    DENHOLM ROBYN M
    Director
    $30.81M
    @ $274.12 · 2025-05-06
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.14M
    @ $284.40 · 2025-05-01
    DENHOLM ROBYN M
    Director
    $32.10M
    @ $285.58 · 2025-04-29
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.00M
    @ $250.00 · 2025-04-07
    MURDOCH JAMES RUPERT
    Director
    $13.19M
    @ $240.79 · 2025-03-10
    TANEJA VAIBHAV
    Chief Financial Officer
    $718,111
    @ $268.75 · 2025-03-06
    DENHOLM ROBYN M
    Director
    $33.67M
    @ $299.61 · 2025-03-03
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.78M
    @ $296.02 · 2025-03-03
    MUSK KIMBAL J
    Director
    $27.59M
    @ $367.87 · 2025-02-06
    DENHOLM ROBYN M
    Director
    $43.16M
    @ $384.04 · 2025-02-03
    TANEJA VAIBHAV
    Chief Financial Officer
    $2.68M
    @ $383.11 · 2025-02-03
    WILSON - THOMPSON KATHLEEN
    Director
    $41.16M
    @ $411.63 · 2025-01-06
    TANEJA VAIBHAV
    Chief Financial Officer
    $2.89M
    @ $413.56 · 2025-01-06
    TANEJA VAIBHAV
    Chief Financial Officer
    $975,015
    @ $374.29 · 2024-12-06
    WILSON - THOMPSON KATHLEEN
    Director
    $35.25M
    @ $352.54 · 2024-12-04
    DENHOLM ROBYN M
    Director
    $39.79M
    @ $354.06 · 2024-12-02
    TANEJA VAIBHAV
    Chief Financial Officer
    $2.48M
    @ $354.43 · 2024-12-02
    DENHOLM ROBYN M
    Director
    $35.34M
    @ $314.44 · 2024-11-15
    WILSON - THOMPSON KATHLEEN
    Director
    $34.60M
    @ $346.02 · 2024-11-11
    TANEJA VAIBHAV
    Chief Financial Officer
    $3.80M
    @ $316.91 · 2024-11-11
    MUSK KIMBAL J
    Director
    $15.14M
    @ $250.23 · 2024-11-01
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.01M
    @ $251.76 · 2024-11-01
    TANEJA VAIBHAV
    Chief Financial Officer
    $1.00M
    @ $250.00 · 2024-10-24
    TANEJA VAIBHAV
    Chief Financial Officer
    $2.00M
    @ $250.00 · 2024-09-23
    ZHU XIAOTONG
    Officer
    $65,867
    @ $221.77 · 2024-09-06
    DENHOLM ROBYN M
    Director
    $14.60M
    @ $219.96 · 2024-07-25
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    HCA
    FearGreed
    😨Fear(39/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    TSLA
    FearGreed
    😐Neutral(45/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    HCA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
    TSLA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
    View HCA Full AnalysisView TSLA Full Analysis

    Frequently Asked Questions: HCA vs TSLA

    Is HCA Healthcare, Inc. or Tesla, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, HCA trades at a 28.2% margin of safety (intrinsic value $523 vs. price $375), compared to TSLA's -206.1% margin of safety (intrinsic $131 vs. $400).

    Which stock has a wider economic moat, HCA Healthcare, Inc. or Tesla, Inc.?

    HCA scores 95/100 (Wide moat), while TSLA scores 31/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is HCA Healthcare, Inc. in financial distress?

    HCA's Altman Z-Score of 2.7 places it in the Grey zone, signaling elevated bankruptcy risk. TSLA scores 19.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, HCA Healthcare, Inc. or Tesla, Inc.?

    HCA Healthcare, Inc. (HCA) generates a 9.2% free cash flow yield, compared to Tesla, Inc.'s 0.3%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, HCA Healthcare, Inc. or Tesla, Inc.?

    HCA earns 18.1% ROIC versus TSLA's 3.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.